Theophylline PCD Pharma Franchise Company
Cafoli Lifecare is a WHO-GMP certified pharmaceutical company offering 10 Theophylline formulations for PCD pharma franchise, distributors and monopoly marketing partners across India. The range covers sustained-release tablets and injections, including respiratory combinations.
What is Theophylline?
Theophylline is a methylxanthine bronchodilator that relaxes airway smooth muscle and reduces airway inflammation, improving breathing in obstructive airway disease. It is used for asthma and COPD, typically in sustained-release form, and requires careful dosing because of its narrow therapeutic range. Reference: PubChem.
Available Theophylline Formulations
Cafoli Lifecare's Theophylline portfolio is available as Tablet and Injection, supporting maintenance and acute respiratory prescribing from a single supplier.
Therapeutic Applications
Theophylline is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) and for reversible airway obstruction. It is prescribed by pulmonologists, chest specialists and general physicians, often combined with etofylline or expectorants.
Why Theophylline is a High-Potential Molecule for Distributors
Respiratory disease is a large, chronic-therapy segment in India, and Theophylline remains a cost-effective oral bronchodilator widely used in general and chest practice. Its established prescribing base and combination options provide steady, repeatable demand for a respiratory franchise range.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers monopoly (district-wise) distribution rights, WHO-GMP and DCGI-approved manufacturing, attractive net rates, complete promotional inputs (visual aids, MR bags, product cards) and prompt dispatch — trusted by 1000+ franchise partners across India.
References
- PubChem – Theophylline
- PubMed – Theophylline literature
Our formulations of Theophylline find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: